These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

393 related items for PubMed ID: 2953290

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Depo-Provera--ethical issues in its testing and distribution.
    Potts M, Paxman JM.
    J Med Ethics; 1984 Mar; 10(1):9-20. PubMed ID: 6231379
    [Abstract] [Full Text] [Related]

  • 3. Depo Provera: still controversial.
    Wren LM.
    Int Health News; 1988 Feb; 9(2):2-3, 8. PubMed ID: 12179873
    [Abstract] [Full Text] [Related]

  • 4. A case for concern?
    Gartland A.
    Nurs Times; 1988 Feb; 79(18):10-1. PubMed ID: 6222288
    [Abstract] [Full Text] [Related]

  • 5. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar; 4(3):25-7. PubMed ID: 12266161
    [Abstract] [Full Text] [Related]

  • 6. Depo-Provera: a critical analysis.
    Minkin S.
    Women Health; 1980 Mar; 5(2):49-69. PubMed ID: 6451987
    [Abstract] [Full Text] [Related]

  • 7. The Food and Drug Administration and medroxyprogesterone acetate. What are the issues?
    Rosenfield A, Maine D, Rochat R, Shelton J, Hatcher RA.
    JAMA; 1983 Jun 03; 249(21):2922-8. PubMed ID: 6221125
    [Abstract] [Full Text] [Related]

  • 8. Depo-Provera: just another contraceptive?
    Jones M.
    Fertil Contracept; 1978 Apr 03; 2(2):26-9. PubMed ID: 12336094
    [Abstract] [Full Text] [Related]

  • 9. Depo-Provera highly effective as injectable contraceptive.
    Denniston GC.
    Contracept Technol Update; 1985 Dec 03; 6(12):167-8. PubMed ID: 12280301
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Depot medroxyprogesterone acetate pioneers. A retrospective study at a North Carolina Health Department.
    Potter LS, Dalberth BT, Cañamar R, Betz M.
    Contraception; 1997 Nov 03; 56(5):305-12. PubMed ID: 9437559
    [Abstract] [Full Text] [Related]

  • 12. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan 03; 13(1):16, 18. PubMed ID: 12343460
    [Abstract] [Full Text] [Related]

  • 13. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents.
    Polaneczky M, Liblanc M.
    J Adolesc Health; 1998 Aug 03; 23(2):81-8. PubMed ID: 9714170
    [Abstract] [Full Text] [Related]

  • 14. FDA gives final approval to Depo amid concerns over safety, cost and coercion.
    Wash Memo Alan Guttmacher Inst; 1992 Nov 12; (17):2-3. PubMed ID: 12344620
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The contraceptive use of depot medroxyprogesterone acetate.
    Hickey M, Fraser I.
    Clin Obstet Gynecol; 1995 Dec 12; 38(4):849-58. PubMed ID: 8616981
    [Abstract] [Full Text] [Related]

  • 19. Forearm bone density in users of Depo-Provera as a contraceptive method.
    Bahamondes L, Perrotti M, Castro S, Faúndes D, Petta C, Bedone A.
    Fertil Steril; 1999 May 12; 71(5):849-52. PubMed ID: 10231044
    [Abstract] [Full Text] [Related]

  • 20. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov 12; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.